Clearmind medicine to host live webinar “gazing through the crystal ball” featuring leading psychedelic experts

Vancouver, canada, april 21, 2025 (globe newswire) -- clearmind medicine inc. (nasdaq: cmnd), (fse: cwy0) (“clearmind” or the "company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, is pleased to announce its upcoming live webinar titled "gazing through the crystal ball." the event is scheduled for may 21, 2025, at 12:00 pm et (9:00 am pt) and will feature a distinguished panel of experts discussing the evolving landscape of psychedelic science and business in the context of changing fda policies and political climates.
BLL Ratings Summary
BLL Quant Ranking